Abstract
Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Current Psychopharmacology
Title:Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments
Volume: 5
Author(s): Maura Southwell and Scott McRobert
Affiliation:
Keywords: Melatonin, Danio rerio, zebrafish, model organism, exogenous melatonin, sleep disorders, treatment.
Abstract: Background: Melatonin is an evolutionarily highly conserved molecule. In humans, exogenous melatonin has been shown to entrain circadian rhythms to light dark cycles and act as an antioxidant. Many complex brain disorders, such as autism and Alzheimer's disease, are associated with abnormal melatonin production or melatonin metabolism. Exogenous melatonin may serve as a potential treatment to improve sleeping patterns and delay neuronal deterioration.
Objective: Here we review the advantages of using zebrafish to study the pharmacology of exogenous melatonin treatments to rescue endogenous melatonin abnormalities.
Method: We perform a literature review to describe the human melatonin system, zebrafish melatonin system, zebrafish advantages as a model organism, and melatonin research using zebrafish.
Conclusions: Zebrafish is a model organism for genetics, physiology, chronobiology, gerontology, and pharmacology studies. Future melatonin research can incorporate all of these fields to better understand melatonin mechanisms in wildtype and mutant zebrafish to discover new potential treatments. A standardized treatment method for all developmental stages should be established to encourage interdisciplinary work.
Export Options
About this article
Cite this article as:
Southwell Maura and McRobert Scott, Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments, Current Psychopharmacology 2016; 5 (2) . https://dx.doi.org/10.2174/2211556005666160526111529
DOI https://dx.doi.org/10.2174/2211556005666160526111529 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Planar Bioadhesive Microdevices: A New Technology for Oral Drug Delivery
Current Pharmaceutical Biotechnology Regulation of Autophagy in Oxygen-Dependent Cellular Stress
Current Pharmaceutical Design Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Rheumatoid Arthritis: A Clinical Overview of New Diagnostic and Treatment Approaches
Current Topics in Medicinal Chemistry <i>In vivo</i> Anticancer Potential of Hydroxamic Acid Derivatives
Current Topics in Medicinal Chemistry Beyond Hemostasis: The Role of Platelets in Inflammation, Malignancy and Infection
Cardiovascular & Hematological Disorders-Drug Targets Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?
Current Cancer Drug Targets New Insights on the Antitumoral Properties of Prodiginines
Current Medicinal Chemistry Effect of Paclitaxel-Loaded PLGA Nanoparticles on MDA-MB Type Cell Lines: Apoptosis and Cytotoxicity Studies
Current Pharmaceutical Design Preface [Hot Topic: Therapeutic Manipulation of the Immune System: Old and New Therapeutic Approaches (Executive Editor : Emilio Jirillo)]
Current Pharmaceutical Design Protein Kinase Homology Models: Recent Developments and Results
Current Medicinal Chemistry The Advancement of Human Serum Albumin-Based Molecular Probes for Molecular Imaging
Current Pharmaceutical Design Current Evidence and Potential Mechanisms of Therapeutic Action of PEDF in Cervical Cancer Treatment
Current Molecular Medicine A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3
Anti-Cancer Agents in Medicinal Chemistry Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets CYP4Z1 – A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer
Current Pharmaceutical Design Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†
Anti-Cancer Agents in Medicinal Chemistry Prediction of Late Recurrence and Distant Metastasis in Early-stage Breast Cancer: Overview of Current and Emerging Biomarkers
Current Drug Targets